ProPhase Labs Inc Cash Flow Conversion Efficiency
ProPhase Labs Inc cash flow conversion efficiency. Based on the latest financial reports, ProPhase Labs Inc (PRPH) has a cash flow conversion efficiency ratio of 0.025x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-78.00K) by net assets ($-3.11 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of ProPhase Labs Inc (1996–2025)
Cash flow conversion efficiency of ProPhase Labs Inc from 1996 to 2025. This chart illustrates how ProPhase Labs Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View ProPhase Labs Inc stock price for real-time trading data and today's change.
ProPhase Labs Inc Cash Flow Conversion Ratio Explained
ProPhase Labs Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
ProPhase Labs Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of ProPhase Labs Inc ranked by their cash flow conversion efficiency. Also see PRPH company net worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Kendrick Resources PLC
LSE:KEN
|
-1.911x |
|
Veg of Lund AB
ST:VOLAB
|
-0.083x |
|
Dianomi PLC
LSE:DNM
|
-0.364x |
|
Atlantis Resources Ltd
LSE:SAE
|
-0.022x |
|
Murray & Roberts Holdings Ltd
JSE:MUR
|
0.535x |
|
TARGA EXPLORATION CORP.
F:V6Y
|
N/A |
|
Vianet Group Plc
LSE:VNET
|
0.084x |
|
Cadence Minerals PLC
LSE:KDNC
|
-0.045x |
Annual Cash Flow Conversion Efficiency for ProPhase Labs Inc (1996–2025)
The table below shows the annual cash flow conversion efficiency of ProPhase Labs Inc from 1996 to 2025. Review PRPH FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $3.51 Million | $-8.34 Million | -2.379x | +0.28% |
| 2024-12-31 | $7.35 Million | $-17.54 Million | -2.385x | -937.94% |
| 2023-12-31 | $49.38 Million | $-11.35 Million | -0.230x | -151.21% |
| 2022-12-31 | $63.63 Million | $28.55 Million | 0.449x | +293.16% |
| 2021-12-31 | $58.63 Million | $-13.62 Million | -0.232x | +5.40% |
| 2020-12-31 | $10.56 Million | $-2.59 Million | -0.246x | -227.91% |
| 2019-12-31 | $11.23 Million | $-841.00K | -0.075x | +41.68% |
| 2018-12-31 | $16.50 Million | $-2.12 Million | -0.128x | -49.70% |
| 2017-12-31 | $33.09 Million | $-2.84 Million | -0.086x | -8.34% |
| 2016-12-31 | $5.96 Million | $-472.00K | -0.079x | +80.01% |
| 2015-12-31 | $8.83 Million | $-3.50 Million | -0.396x | -31.98% |
| 2014-12-31 | $10.72 Million | $-3.22 Million | -0.300x | -432.47% |
| 2013-12-31 | $12.60 Million | $1.14 Million | 0.090x | +118.04% |
| 2012-12-31 | $11.45 Million | $-5.73 Million | -0.500x | -166.43% |
| 2011-12-31 | $11.23 Million | $-2.11 Million | -0.188x | +28.78% |
| 2010-12-31 | $13.46 Million | $-3.55 Million | -0.264x | -933.02% |
| 2009-12-31 | $14.06 Million | $445.00K | 0.032x | +118.40% |
| 2008-12-31 | $17.77 Million | $-3.06 Million | -0.172x | -205.56% |
| 2007-12-31 | $23.30 Million | $-1.31 Million | -0.056x | -250.57% |
| 2006-12-31 | $25.59 Million | $956.94K | 0.037x | -77.76% |
| 2005-12-31 | $25.37 Million | $4.27 Million | 0.168x | -20.79% |
| 2004-12-31 | $21.96 Million | $4.66 Million | 0.212x | +556.59% |
| 2003-12-31 | $20.79 Million | $-966.23K | -0.046x | -257.52% |
| 2002-12-31 | $18.42 Million | $543.64K | 0.030x | +156.01% |
| 2001-12-31 | $21.20 Million | $-1.12 Million | -0.053x | +40.24% |
| 2000-12-31 | $21.21 Million | $-1.87 Million | -0.088x | -277.69% |
| 1999-12-31 | $26.20 Million | $1.30 Million | 0.050x | -75.14% |
| 1998-12-31 | $44.60 Million | $8.90 Million | 0.200x | -7.54% |
| 1997-12-31 | $41.70 Million | $9.00 Million | 0.216x | +123.54% |
| 1996-12-31 | $1.20 Million | $-1.10 Million | -0.917x | -- |
About ProPhase Labs Inc
ProPhase Labs, Inc. develops and commercializes novel drugs, dietary supplements, and compounds in the United States. It operates through two segments: Diagnostic Services and Consumer Products. The company provides a range of dietary supplements under the TK supplements, including Legendz XL, a male sexual enhancement; and Triple Edge XL, an energy and stamina booster. It also develops BE-Smart … Read more